Takeda Pharmaceutical
TAK
#457
Rank
C$70.88 B
Marketcap
C$21.30
Share price
0.78%
Change (1 day)
15.24%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): C$2.77 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are C$29.52 Billion. In 2024 the company made an earning of C$3.05 Billion a decrease over its 2023 earnings that were of C$3.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$2.77 B-9.17%
2024 C$3.05 B-2.41%
2023 C$3.12 B-28.14%
2022 C$4.35 B-40.9%
2021 C$7.36 B78.24%
2020 C$4.12 B246.1%
2019 C$1.19 B-48.79%
2018 C$2.32 B-23.64%
2017 C$3.05 B21.7%
2016 C$2.50 B-253.01%
2015 -C$1.64 Billion-159.65%
2014 C$2.74 B13%
2013 C$2.43 B2.46%
2012 C$2.37 B-57.05%
2011 C$5.52 B-10.49%
2010 C$6.17 B-3.99%
2009 C$6.42 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.29 B 1,481.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$12.44 B 344.15%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
C$16.20 B 478.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.44 B 701.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Seagen
SGEN
-C$1.09 Billion-138.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
C$1.25 B-55.15%๐Ÿ‡ฎ๐Ÿ‡ณ India
Amgen
AMGN
C$11.27 B 302.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$12.74 B 355.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$31.56 B 1,026.95%๐Ÿ‡บ๐Ÿ‡ธ USA